Specific molecular targeting of renal injury in obstructive nephropathy
- PMID: 16988728
- DOI: 10.1038/sj.ki.5001815
Specific molecular targeting of renal injury in obstructive nephropathy
Abstract
Progression of most renal disease involves tubulointerstitial injury, characterized by tubular atrophy, inflammatory cell infiltration, and interstitial fibrosis. Transforming growth factor-beta1 is central in this process. As reported by Moon et al., molecular targeting of the transforming growth factor-beta1 signaling pathway can markedly suppress renal injury resulting from unilateral ureteral obstruction, an established model of obstructive nephropathy. Specific kinase inhibitors are promising therapeutic agents to slow or attenuate progressive renal fibrosis.
Comment on
-
IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.Kidney Int. 2006 Oct;70(7):1234-43. doi: 10.1038/sj.ki.5001775. Epub 2006 Aug 23. Kidney Int. 2006. PMID: 16929250
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
